News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EDAP TMS S.A. (EDAP) Delivers Focal One® Device For Focal Treatment Of Prostate Cancer To Hospital In Poland


2/11/2014 9:38:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LYON, France, Feb. 11, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland. Focal One is the first robotic HIFU device dedicated to the focal approach for prostate cancer therapy. It combines the three essential components to efficiently perform a focal treatment: state-of-the-art imaging to localized tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, utmost precision of robotic HIFU treatment focused only on identified targeted cancer areas, and immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES